Suppr超能文献

凝血功能障碍、抗凝或抗血栓治疗在切口疝修补术中重要吗?来自 Herniamed 登记处的数据。

Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry.

机构信息

Department of Surgery, Clinic for Visceral Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.

Department of Surgery and Center for Minimally Invasive Surgery, Academic Teaching Hospital of Charité Medical School, Vivantes Hospital, Neue Bergstrasse 6, 13585, Berlin, Germany.

出版信息

Surg Endosc. 2018 Sep;32(9):3881-3889. doi: 10.1007/s00464-018-6127-y. Epub 2018 Feb 28.

Abstract

BACKGROUND

A considerable number of patients undergoing incisional hernia repair are on anticoagulant or antiplatelet therapy or have existing coagulopathy which may put them at higher risk for postoperative bleeding complications. Data about the optimal treatment of these patients are sparse. This analysis attempts to determine the rate of postoperative bleeding complications following incisional hernia repair and the consecutive rate of reoperation among patients with coagulopathy or receiving antiplatelet and anticoagulant therapy (higher risk group) compared to patients who do not have a higher risk (normal risk group).

METHODS

Out of the 43,101 patients documented in the Herniamed Registry who had an incisional hernia repair, 6668 (15.5%) were on anticoagulant or antithrombotic therapy or had existing coagulopathy. The implication of that higher risk profile for onset of postoperative bleeding was investigated in multivariable analysis. Hence, other influential variables were identified.

RESULTS

The rate of postoperative bleeding in the higher risk group was 3.9% (n = 261) and significantly higher compared to the normal risk group at 1.6% (n = 564) (OR 2.001 [1.699; 2.356]; p < 0.001). Additionally, male gender, use of drains, larger defect size, open incisional hernia repair, lower BMI, and higher ASA score significantly increased the risk of postoperative bleeding. The rate of reoperations due to postoperative bleeding was significantly increased in the higher risk group compared to the normal risk group (2.4 vs. 1.0%; OR 1.217 [1.071; 1.382]; p = 0.003). Likewise, the postoperative general complication rate (6.04 vs. 3.66%; p < 0.001) as well as the mortality rate (0.46 vs. 0.17%; p < 0.001) were significantly higher in the higher risk group.

CONCLUSIONS

Patients with anticoagulant or antiplatelet therapy or existing coagulopathy who undergo incisional hernia repair have a significantly higher risk for onset of postoperative bleeding. The risk of bleeding complications and complication-related reoperations seems to be lower after laparoscopic intraperitoneal onlay mesh.

摘要

背景

相当数量的接受切口疝修补术的患者正在接受抗凝或抗血小板治疗,或存在凝血障碍,这可能使他们术后出血并发症的风险更高。关于这些患者的最佳治疗方法的数据很少。本分析试图确定在接受抗凝或抗血小板治疗的患者(高风险组)和无高风险(正常风险组)的患者中,切口疝修补术后出血并发症的发生率以及凝血障碍患者的再次手术率。

方法

在 Herniamed 注册中心记录的 43101 例接受切口疝修补术的患者中,有 6668 例(15.5%)正在接受抗凝或抗血栓治疗或存在凝血障碍。多变量分析研究了这种更高风险对术后出血的影响。因此,确定了其他有影响的变量。

结果

高风险组的术后出血率为 3.9%(n=261),明显高于正常风险组的 1.6%(n=564)(OR 2.001[1.699;2.356];p<0.001)。此外,男性、引流管的使用、更大的缺损大小、开放式切口疝修补术、较低的 BMI 和较高的 ASA 评分显著增加了术后出血的风险。高风险组因术后出血导致再次手术的发生率明显高于正常风险组(2.4 对 1.0%;OR 1.217[1.071;1.382];p=0.003)。同样,高风险组的术后一般并发症发生率(6.04 对 3.66%;p<0.001)和死亡率(0.46 对 0.17%;p<0.001)也明显较高。

结论

接受抗凝或抗血小板治疗或存在凝血障碍的切口疝修补术患者术后出血的风险显著增加。腹腔镜腹腔内补片修补术的出血并发症风险和相关并发症再次手术似乎较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82e3/6096530/8803d2381ba8/464_2018_6127_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验